FERNDALE, Mich. -- A new study on securement for central vascular access devices (CVAD) suggests that subcutaneous anchor securement systems (SASS) are shown to be more effective at keeping central ...

EU surgeons will also be able to use the device as a cardiovascular support system during coronary bypass surgery. The Danvers, MA-based company describes the Impella cVAD as being designed to give " ...

A new study on securement for central vascular access devices (CVAD) suggests that subcutaneous anchor securement systems (SASS) are shown to be more effective at keeping central catheters in place, ...

Central venous access devices in fluoropyrimidine therapy are associated with complications; however, reliable data are lacking regarding their natural history, associated complications and infusion ...

A pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy based on capecitabine: Polymorphisms in thymidilyate synthase and DNA repair genes. This is an ASCO ...

Heart devices technologies company Abiomed Inc. (ABMD) reported first quarter fiscal 2013 adjusted (excluding one-time items except stock-based compensation expenses) earnings per share of 8 cents, ...